Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Spinazzi

Showing results (41-50 of 46) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 46 results.
Neuroradiology|April 11, 2002
Magnetic resonance imaging of metastatic disease to the brain with gadobenate dimeglumineD Balériaux, C Colosimo, J Ruscalleda, et al.
NPJ Vaccines|May 19, 2026
Vaccination in individuals with Down syndrome: immune vulnerability, safety, efficacy and opportunitiesBernard Khor, Noemi A Spinazzi, Lina R Patel, et al.
AJNR. American Journal of Neuroradiology|July 18, 2015
The Benefits of High Relaxivity for Brain Tumor Imaging: Results of a Multicenter Intraindividual Crossover Comparison of Gadobenate Dimeglumine with Gadoterate Meglumine (The BENEFIT Study)M Vaneckova, M Herman, M P Smith, et al.
Brain Communications|June 15, 2026
Immunosuppression in down syndrome regression disorder: a prospective observational cohort studyJonathan D Santoro, Lilia Kazerooni, Maeve C Lucas, et al.
Radiology|June 1, 2000
Focal liver lesions: evaluation of the efficacy of gadobenate dimeglumine in MR imaging--a multicenter phase III clinical studyJ Petersein, A Spinazzi, A Giovagnoni, et al.
Translational Psychiatry|August 8, 2023
Immunotherapy responsiveness and risk of relapse in Down syndrome regression disorderJonathan D Santoro, Noemi A Spinazzi, Robyn A Filipink, et al.
Pageof 5

Showing results (41-50 of 46) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 46 results.
Neuroradiology|April 11, 2002
Magnetic resonance imaging of metastatic disease to the brain with gadobenate dimeglumineD Balériaux, C Colosimo, J Ruscalleda, et al.
NPJ Vaccines|May 19, 2026
Vaccination in individuals with Down syndrome: immune vulnerability, safety, efficacy and opportunitiesBernard Khor, Noemi A Spinazzi, Lina R Patel, et al.
AJNR. American Journal of Neuroradiology|July 18, 2015
The Benefits of High Relaxivity for Brain Tumor Imaging: Results of a Multicenter Intraindividual Crossover Comparison of Gadobenate Dimeglumine with Gadoterate Meglumine (The BENEFIT Study)M Vaneckova, M Herman, M P Smith, et al.
Brain Communications|June 15, 2026
Immunosuppression in down syndrome regression disorder: a prospective observational cohort studyJonathan D Santoro, Lilia Kazerooni, Maeve C Lucas, et al.
Radiology|June 1, 2000
Focal liver lesions: evaluation of the efficacy of gadobenate dimeglumine in MR imaging--a multicenter phase III clinical studyJ Petersein, A Spinazzi, A Giovagnoni, et al.
Translational Psychiatry|August 8, 2023
Immunotherapy responsiveness and risk of relapse in Down syndrome regression disorderJonathan D Santoro, Noemi A Spinazzi, Robyn A Filipink, et al.
Pageof 5